Form 4: Clorox Executive Sells Shares for Tax Obligations

Clorox EVP Chris T Hyder disposed of 133 common shares to cover tax obligations related to restricted stock units.

Summary

• Chris T Hyder, Executive Vice President and Group President of Health & Hygiene at The Clorox Company, reported a transaction on December 12, 2025.
• The transaction involved the disposition of 133 shares of Clorox Common Stock at a price of $102.83 per share.
• This disposition was a withholding by the company to satisfy employment tax obligations applicable to restricted stock units previously granted to retirement-eligible employees.
• Following this reported transaction, Chris T Hyder beneficially owns 35,000 shares of Clorox Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the withholding of shares for tax obligations related to restricted stock units, which is a neutral event and does not indicate a change in company fundamentals or executive sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is a common occurrence across publicly traded companies and does not reflect broader industry trends or competitive positioning.

Related Party Transactions

• Disposition of 133 common shares by EVP Chris T Hyder to The Clorox Company to satisfy employment tax obligations on restricted stock units, a standard compensation-related transaction.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, small-scale transaction for tax purposes, not indicative of a change in company value or executive confidence.
• Employees: No direct impact beyond the executive involved in the transaction.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by an executive to cover tax obligations related to restricted stock units. Such a transaction is a standard part of executive compensation and does not typically indicate a change in the company's fundamentals or the executive's confidence, thus not warranting a change in investment recommendation based solely on this filing.

Keywords

Clorox, CLX, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation